Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,18117,200 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Expanding the Druggable Human Genome
NATIONAL CANCER INSTITUTE Iowa State University United States 2021 – 2026

PROJECT SUMMARY: Most small molecule drugs elicit their effects by modulating protein function, despite the fact that only a small portion of the genome is translated (~1-2%). Furt...

$398.1K
USD
Completed NON-SBIR/STTR RPGS
Transforming Human Pancreatic Cancer Into An Immunologic Disease
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2026

Pancreatic ductal adenocarcinoma (PDA) is rising in incidence but remains deadly for most patients. Some progress has occurred in activating immune responses against PDA, however t...

$25.31M
USD
Completed NON-SBIR/STTR RPGS
OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

PROJECT SUMMARY. Cancer survivors have unique healthcare needs including risk for serious late effects, ongoing surveillance, lifestyle modifications to reduce second cancer risk,...

$6.45M
USD
Completed NON-SBIR/STTR RPGS
The Impact of Cigarillo Warnings on Purchasing and Smoking Behaviors Among Young Adult Cigarillo Users
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2021 – 2022

Project Summary Cigarillo use remains a public health concern, particularly among vulnerable populations. Young adults, including those who are Black or African American, have the...

$1.5M
USD
Completed NON-SBIR/STTR RPGS
Validation of predictive liquid biomarkers for patients with metastatic prostate cancer
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2023

Project Summary/Abstract The University of Wisconsin Carbone Cancer Center (UWCCC), Duke University and Memorial Sloan Kettering Cancer Center (MSKCC) seek support for establishing...

$1.6M
USD
Completed NON-SBIR/STTR RPGS
Modulation of Mcl-1 for Treatment of Lung Cancer
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2026

Summary KRAS mutations activate Raf/MEK/ERK1/2 that can directly phosphorylate Mcl-1 at T163, enhancing Mcl-1’s function. KRAS mutations also activate PI3K/AKT that can inactivate...

$4.25M
USD
Completed NON-SBIR/STTR RPGS
Enhancement of ADC selectivity by inverse targeting: Mechanistic studies and optimization
NATIONAL CANCER INSTITUTE State University of New York At Buffalo United States 2021 – 2026

Cancer is a major cause of morbidity and mortality in the US, with 1.8 million cases and 600 thousand cancer deaths projected for 2020. Substantial progress in cancer treatment has...

$3.56M
USD
Completed NON-SBIR/STTR RPGS
Modulation of Mcl-1 for Treatment of Lung Cancer
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2026

Summary KRAS mutations activate Raf/MEK/ERK1/2 that can directly phosphorylate Mcl-1 at T163, enhancing Mcl-1’s function. KRAS mutations also activate PI3K/AKT that can inactivate...

$4.25M
USD
Completed OTHER RESEARCH-RELATED
Malawi Cancer Outcomes Research Program (M-CORP)
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2026

PROJECT SUMMARY Globally, there are more deaths from cancer than from HIV, tuberculosis, and malaria combined. In 2018, there were more than 18 million new cancer cases and 9.5 mil...

$2.68M
USD
Completed NON-SBIR/STTR RPGS
Understanding the Mechanisms of DC Licensing in CD8 T Cell Priming
NATIONAL CANCER INSTITUTE Washington University United States 2021 – 2026

ABSTRACTEffective responses to viruses, intracellular pathogens and tumors rely on the successful expansion and arming of cytolytic CD8 T cells from a naïve and quiescent T cell re...

$4.67M
USD
Completed NON-SBIR/STTR RPGS
HTS for the discovery of activators of NK cell cytotoxicity
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2021 – 2025

Abstract Natural killer (NK) cells are lymphocytes that are capable of killing malignant cells without antigen-specific receptor recognition. Due to this property, NK cells have be...

$3.73M
USD
Completed TRAINING, INDIVIDUAL
A patient-specific hiPSC model of breast cancer to identify genetic determinants of subclonal response and resistance to PARP inhibitors
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2024

PROJECT SUMMARY Breast cancer is the most common cancer among women worldwide, affecting one in eight women in the United States during their lifetime. Existing patient-derived mod...

$429.1K
USD
Active NON-SBIR/STTR RPGS
OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2027

PROJECT SUMMARY. Cancer survivors have unique healthcare needs including risk for serious late effects, ongoing surveillance, lifestyle modifications to reduce second cancer risk,...

$4.16M
USD
Completed NON-SBIR/STTR RPGS
Testing a Clinician and Patient Intervention to Promote smoking Cessation Among Pregnant Women
NATIONAL CANCER INSTITUTE Duke University United States 2021 – 2026

Perinatal smoking negatively affects the baby and mother as well as healthcare costs; yet, up to one third of women who smoke continue to do so during pregnancy. We tested an SMS t...

$5.55M
USD
Completed NON-SBIR/STTR RPGS
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY Small cell lung cancer (SCLC) is an aggressive malignancy for which there is a critical need for improved therapeutic strategies. While targeted and immune-based th...

$5.62M
USD
Completed NON-SBIR/STTR RPGS
B cell antigen receptor (BCR)-driven mechanistic connection between B cell lymphomagenesis and autoimmunity
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Title: B cell antigen receptor (BCR)-driven mechanistic connection between B cell lymphomagenesis and autoimmunity Non-Hodgkin's lymphomas (NHL) are a...

$3.56M
USD
Active NON-SBIR/STTR RPGS
Supplement: Effects of Comorbidity Management and Complex Care Coordination on Cancer Caregivers
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2027

PROJECT SUMMARY. The overarching goal of this Diversity Supplement is to prepare and launch Dr. Maria Lizette Rangel into an academic career as an independent scientist. Dr. Rangel...

$1.27M
USD
Completed NON-SBIR/STTR RPGS
Racial and Socioeconomic Disparities in Breast Cancer Diagnostic Work Up and Outcomes
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2026

Project Summary U.S. women of minority race/ethnicity, lower education, lower income, rural residence, and the underinsured experience higher breast cancer disease burden and lower...

$5.82M
USD
Completed NON-SBIR/STTR RPGS
Validation of predictive liquid biomarkers for patients with metastatic prostate cancer
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

Project Summary/Abstract The University of Wisconsin Carbone Cancer Center (UWCCC), Duke University and Memorial Sloan Kettering Cancer Center (MSKCC) seek support for establishing...

$3.63M
USD
Completed OTHER RESEARCH-RELATED
Expanding pharmacological modalities for targeted cancer therapy
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2021 – 2024

Project Summary/Abstract Targeted cancer therapy requires complete and sustained pharmacological inhibition of the respective target, which is often challenging to achieve due to t...

$1.01M
USD